Marco Salvetti

Pubblicazioni

Titolo	Pubblicato in	Anno
Interferon-β therapy specifically reduces pathogenic memory B cells in multiple sclerosis patients by inducing a FAS-mediated apoptosis	IMMUNOLOGY AND CELL BIOLOGY	2016
Geographic population structure in Epstein-Barr Virus revealed by comparative genomics	GENOME BIOLOGY AND EVOLUTION	2016
Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: a pilot study	MULTIPLE SCLEROSIS	2016
Riluzole in patients with hereditary cerebellar ataxia. Authors' reply	LANCET NEUROLOGY	2016
Vaccines in multiple sclerosis. The experience of BCG vaccination	DRUGS OF THE FUTURE	2016
Eosinophilic gastroenteritis in a woman with multiple sclerosis on dimethyl fumarate	NEUROLOGY	2016
Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome	JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY	2016
Use of herbal remedies by multiple sclerosis patients. a nation-wide survey in Italy	NEUROLOGICAL SCIENCES	2016
Conversion from clinically isolated syndrome to multiple sclerosis. a large multicentre study.	MULTIPLE SCLEROSIS	2015
IFN-β and multiple sclerosis: From etiology to therapy and back	CYTOKINE & GROWTH FACTOR REVIEWS	2015
IFN-β and multiple sclerosis. Cross-talking of immune cells and integration of immunoregulatory networks	CYTOKINE & GROWTH FACTOR REVIEWS	2015
Twin studies in multiple sclerosis. A meta-estimation of heritability and environmentality	MULTIPLE SCLEROSIS	2015
Epstein-Barr virus genetic variants are associated with multiple sclerosis	NEUROLOGY	2015
IFN-β Therapy Regulates TLR7-Mediated Response in Plasmacytoid Dendritic Cells of Multiple Sclerosis Patients Influencing an Anti-Inflammatory Status	JOURNAL OF INTERFERON AND CYTOKINE RESEARCH	2015
Progressive MS. from pathophysiology to drug discovery	MULTIPLE SCLEROSIS	2015
Riluzole in patients with hereditary cerebellar ataxia. a randomised, double-blind, placebo-controlled trial	LANCET NEUROLOGY	2015
Association between vaccines and neuroinflammation. time, risks, and benefits	JAMA NEUROLOGY	2015
EBNA2 binds to genomic intervals associated with multiple sclerosis and overlaps with vitamin D receptor occupancy	PLOS ONE	2015
Increased circulating levels of vitamin D binding protein in MS patients	TOXINS	2015
arsenical c-glucoside derivatives with promising antitumor activity	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY	2015

Pubblicazioni

Progetti di Ricerca